REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,229,147 | +17.1% | 7,730 | +4.2% | 0.76% | +14.7% |
| Q2 2023 | $1,049,350 | -17.3% | 7,418 | -1.6% | 0.66% | -30.6% |
| Q1 2023 | $1,269,434 | -19.5% | 7,540 | -19.0% | 0.96% | -22.7% |
| Q4 2022 | $1,576,784 | -9.5% | 9,313 | 0.0% | 1.24% | -15.5% |
| Q3 2022 | $1,743,000 | +15.7% | 9,313 | +0.4% | 1.47% | +14.1% |
| Q2 2022 | $1,506,000 | +64.4% | 9,274 | +90.4% | 1.28% | +112.0% |
| Q1 2022 | $916,000 | -59.8% | 4,872 | -43.4% | 0.61% | -54.4% |
| Q4 2021 | $2,281,000 | +49.8% | 8,613 | +12.9% | 1.33% | +27.3% |
| Q2 2021 | $1,523,000 | +5.1% | 7,628 | +2.4% | 1.04% | -4.0% |
| Q1 2021 | $1,449,000 | +8.2% | 7,451 | +6.6% | 1.09% | -1.5% |
| Q4 2020 | $1,339,000 | – | 6,988 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |